BioNexus Gene Lab Corp
BGLCNasdaqCIK 1737523HealthcareFiscal year ends Dec 31
Reports and events: 101 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-3119:45 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001477932-24-003418 |
| 2024-05-1517:20 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001477932-24-002941 |
| 2024-05-0916:37 ET | 8-K | 3.01 Delisting notice | 0001477932-24-002622 |
| 2024-04-1817:44 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-24-002229 |
| 2024-04-1617:00 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001477932-24-002151 |
| 2024-04-0119:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001477932-24-001695 |
| 2024-03-2619:59 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-09-30 | 0001477932-24-001468 |
| 2024-01-1722:43 ET | SC 13D | Ownership report, active investor | 0001477932-24-000214 |
| 2023-11-2022:10 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001477932-23-008709 |
| 2023-11-1318:40 ET | 8-K | 3.01 Delisting notice | 0001477932-23-008275 |
| 2023-11-0314:55 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001477932-23-008068 |
| 2023-10-3016:14 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001477932-23-007962 |
| 2023-10-1614:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001477932-23-007651 |
| 2023-10-1114:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001477932-23-007555 |
| 2023-09-0715:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001477932-23-006695 |
| 2023-08-1615:26 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001477932-23-006208 |
| 2023-07-2421:28 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-23-005506 |
| 2023-07-2015:29 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-23-005435 |
| 2023-07-1723:20 ET | S-1/A | Registration statement, amended | 0001477932-23-005323 |
| 2023-07-0523:16 ET | S-1/A | Registration statement, amended | 0001477932-23-004992 |
| 2023-05-0915:39 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001477932-23-003193 |
| 2023-05-0922:58 ET | S-1/A | Registration statement, amended | 0001477932-23-003180 |
| 2023-03-3113:57 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001477932-23-002002 |
| 2023-02-1419:37 ET | S-1 | Registration statement | 0001477932-23-000981 |
| 2022-11-1421:38 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001477932-22-008532 |
| 2022-08-1519:57 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001477932-22-006097 |
| 2022-08-1519:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-22-006086 |
| 2022-05-1612:27 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001477932-22-003360 |
| 2022-04-0612:16 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001477932-22-002089 |
| 2021-11-1511:07 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001477932-21-008128 |
| 2021-08-1214:18 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001477932-21-005366 |
| 2021-05-1814:18 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001477932-21-003380 |
| 2021-03-3021:06 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001477932-21-001795 |
| 2021-03-1120:54 ET | 8-K/A | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001477932-21-001370 |
| 2021-01-0716:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 9.01 Financial statements and exhibits | 0001477932-21-000091 |
| 2020-12-3019:09 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001477932-20-007556 |
| 2020-12-2212:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-20-007424 |
| 2020-12-1016:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001477932-20-007190 |
| 2020-11-0914:12 ET | 10-Q/A | Quarterly report, amendedPeriod 2020-09-30 | 0001477932-20-006341 |
| 2020-11-0314:20 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001477932-20-006210 |
| 2020-10-0815:32 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001477932-20-005798 |
| 2020-08-1113:41 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001477932-20-004715 |
| 2020-05-0815:35 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001477932-20-002455 |
| 2020-03-3117:12 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001477932-20-001729 |
| 2019-11-1414:31 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001477932-19-006454 |
| 2019-10-1520:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001477932-19-005881 |
| 2019-08-0919:22 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001551163-19-000195 |
| 2019-05-1517:15 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001551163-19-000126 |
| 2019-03-2716:02 ET | S-1/A | Registration statement, amended | 0001551163-19-000051 |
| 2019-02-2520:30 ET | S-1/A | Registration statement, amended | 0001551163-19-000043 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.